LSV ASSET MANAGEMENT - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 55 filers reported holding PSYCHEMEDICS CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LSV ASSET MANAGEMENT ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2018$531,000
-31.6%
33,508
-18.8%
0.00%0.0%
Q3 2018$776,000
-9.7%
41,287
-7.6%
0.00%0.0%
Q2 2018$859,000
-7.0%
44,6880.0%0.00%0.0%
Q1 2018$924,000
-0.8%
44,688
-1.3%
0.00%0.0%
Q4 2017$931,000
+64.8%
45,288
+47.6%
0.00%0.0%
Q3 2017$565,000
-14.1%
30,688
+16.2%
0.00%0.0%
Q2 2017$658,000
+265.6%
26,404
+193.4%
0.00%
Q1 2017$180,0009,0000.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 256,359$4,725,0004.06%
Moors & Cabot, Inc. 337,060$6,218,0000.90%
CARL DOMINO INC 11,236$207,0000.25%
Gs Investments, Inc. 15,500$285,665,0000.23%
Ativo Capital Management LLC 46,327$854,0000.23%
North Star Investment Management Corp. 78,271$1,443,0000.18%
RBF Capital, LLC 78,495$1,447,0000.18%
Uniplan Investment Counsel, Inc. 191,822$3,535,0000.15%
QUANTUM CAPITAL MANAGEMENT 30,669$565,0000.13%
CRAWFORD INVESTMENT COUNSEL INC 205,493$3,787,0000.12%
View complete list of PSYCHEMEDICS CORP shareholders